blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3160234

EP3160234 - COMPOSITIONS FOR USE IN PREVENTING AND TREATING OPTHALMIC, HAND OR FEET BIOFILM GROWTH [Right-click to bookmark this link]
Former [2017/18]ANTIMICROBIAL-ANTIBIOFILM COMPOSITIONS AND METHODS OF USE THEREOF FOR PERSONAL CARE PRODUCTS
[2021/09]
StatusNo opposition filed within time limit
Status updated on  10.06.2022
Database last updated on 12.07.2024
FormerThe patent has been granted
Status updated on  02.07.2021
FormerGrant of patent is intended
Status updated on  18.02.2021
FormerExamination is in progress
Status updated on  10.08.2019
FormerRequest for examination was made
Status updated on  31.03.2017
FormerThe international publication has been made
Status updated on  27.01.2017
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK		published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Kane Biotech Inc.
162-196 Innovation Drive
Winnipeg, Manitoba R3T 2N2 / CA
[2017/18]
Inventor(s)01 / GAWANDE, Purushottam V.
35 Vestford Place
Winnipeg, Manitoba R3Y 0E6 / CA
02 / LOVETRI, Karen
845 Kilkenny Drive
Winnipeg, Manitoba R3T 4Y4 / CA
03 / YAKANDAWALA, Nandadeva
157 Kinlock Lane
Winnipeg, Manitoba R3T 6B1 / CA
04 / FROEHLICH, Gord
Box 25
Group 310
Rural Route 3
Selkirk, Manitoba R1A 2A8 / CA
05 / MADHYASTHA, Srinivasa
71 Loyola Bay
Winnipeg, Manitoba R3T 3J7 / CA
 [2017/18]
Representative(s)Taylor, Gillian Claire
Reddie & Grose LLP The White Chapel Building
10 Whitechapel High Street
London E1 8QS / GB
[2021/31]
Former [2017/18]Taylor, Gillian Claire
Reddie & Grose LLP
16 Theobalds Road
London WC1X 8PL / GB
Application number, filing date15810908.226.06.2015
[2017/18]
WO2015CA50599
Priority number, dateUS201462018114P27.06.2014         Original published format: US 201462018114 P
[2017/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015196299
Date:30.12.2015
Language:EN
[2015/52]
Type: A1 Application with search report 
No.:EP3160234
Date:03.05.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 30.12.2015 takes the place of the publication of the European patent application.
[2017/18]
Type: B1 Patent specification 
No.:EP3160234
Date:04.08.2021
Language:EN
[2021/31]
Search report(s)International search report - published on:CA30.12.2015
(Supplementary) European search report - dispatched on:EP02.01.2018
ClassificationIPC:A61K31/198, A61K31/194, A61K33/30, A61K45/06, A61K9/00, A61P17/00, A61P27/02, A61P31/00, A61P31/04, A61P31/10, A61K8/27, A61K8/365, A61K8/44, A61Q3/00, A61Q17/00, A01N37/44, A01N59/16
[2021/09]
CPC:
A61K8/44 (EP,US); A01N37/14 (KR); A01N25/04 (KR);
A01N25/30 (KR); A01N37/04 (US); A01N37/44 (EP,US);
A01N59/16 (EP,KR,US); A61B3/125 (EP,US); A61C11/005 (EP,US);
A61K31/194 (EP,KR,US); A61K31/198 (EP,KR,US); A61K33/30 (EP,KR,US);
A61K45/06 (EP,US); A61K8/27 (EP,US); A61K8/362 (US);
A61K8/365 (EP,US); A61K9/0048 (KR,US); A61L12/08 (KR);
A61L2/16 (KR); A61P17/00 (EP); A61P27/02 (EP);
A61P31/00 (EP); A61P31/04 (EP); A61P31/10 (EP);
A61Q17/005 (EP,US); A61Q3/00 (EP,US); A61K2300/00 (KR);
A61K2800/70 (US); Y02A50/30 (EP,US) (-)
C-Set:
A01N59/16, A01N37/36, A01N37/44 (US,EP);
A61K31/194, A61K2300/00 (US,EP);
A61K31/198, A61K2300/00 (US,EP);
A61K33/30, A61K2300/00 (EP,US)
Former IPC [2018/04]A01N59/16, A01N37/44, A01P1/00, A61K31/198, A61K33/30, A61K8/27, A61K8/44, A61L12/08, A61L2/16, A61P31/00, A61Q3/00, A61C11/00, A61B3/125, A61K45/06, A01N37/04, A61K8/362, A61K8/365, A61K31/194, A61K9/00, A61Q17/00
Former IPC [2017/18]A01N59/16, A01N37/44, A01P1/00, A61K31/198, A61K33/30, A61K8/27, A61K8/44, A61L12/08, A61L2/16, A61P31/00, A61Q3/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/18]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:ZUSAMMENSETZUNGEN ZUR VORBEUGUNG UND BEHANDLUNG DES OPTHALMISCHEN, HAND- ODER FUSS-BIOFILM-WACHSTUMS[2021/09]
English:COMPOSITIONS FOR USE IN PREVENTING AND TREATING OPTHALMIC, HAND OR FEET BIOFILM GROWTH[2021/09]
French:COMPOSITIONS DESTINÉES À LA PRÉVENTION ET AU TRAITEMENT DE LA CROISSANCE DES BIOFILMES OPTHALMIQUES, MAINS OU PIEDS[2021/09]
Former [2017/18]ANTIMIKROBIELLE ANTIBIOFILMZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON FÜR KÖRPERPFLEGEPRODUKTE
Former [2017/18]ANTIMICROBIAL-ANTIBIOFILM COMPOSITIONS AND METHODS OF USE THEREOF FOR PERSONAL CARE PRODUCTS
Former [2017/18]COMPOSITIONS ANTI-BIOFILM ET ANTIMICROBIENNES ET LEURS PROCÉDÉS D'UTILISATION POUR DES PRODUITS DE SOINS PERSONNELS
Entry into regional phase26.01.2017National basic fee paid 
26.01.2017Search fee paid 
26.01.2017Designation fee(s) paid 
26.01.2017Examination fee paid 
Examination procedure26.01.2017Examination requested  [2017/18]
26.01.2017Date on which the examining division has become responsible
27.07.2018Amendment by applicant (claims and/or description)
14.08.2019Despatch of a communication from the examining division (Time limit: M04)
16.12.2019Reply to a communication from the examining division
24.03.2020Despatch of a communication from the examining division (Time limit: M02)
27.05.2020Reply to a communication from the examining division
25.08.2020Despatch of a communication from the examining division (Time limit: M02)
20.10.2020Reply to a communication from the examining division
19.02.2021Communication of intention to grant the patent
21.06.2021Fee for grant paid
21.06.2021Fee for publishing/printing paid
21.06.2021Receipt of the translation of the claim(s)
Opposition(s)06.05.2022No opposition filed within time limit [2022/28]
Fees paidRenewal fee
29.06.2017Renewal fee patent year 03
29.06.2018Renewal fee patent year 04
27.06.2019Renewal fee patent year 05
31.03.2020Renewal fee patent year 06
28.06.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.06.2015
AL04.08.2021
CY04.08.2021
CZ04.08.2021
EE04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
MC04.08.2021
MK04.08.2021
RS04.08.2021
SI04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
[2024/22]
Former [2024/20]HU26.06.2015
AL04.08.2021
CY04.08.2021
CZ04.08.2021
EE04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
MC04.08.2021
RS04.08.2021
SI04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2024/18]HU26.06.2015
AL04.08.2021
CZ04.08.2021
EE04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
MC04.08.2021
RS04.08.2021
SI04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2023/08]AL04.08.2021
CZ04.08.2021
EE04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
MC04.08.2021
RS04.08.2021
SI04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/36]AL04.08.2021
CZ04.08.2021
EE04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
RS04.08.2021
SI04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/29]AL04.08.2021
CZ04.08.2021
EE04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
RS04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/26]CZ04.08.2021
EE04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
RS04.08.2021
SK04.08.2021
SM04.08.2021
BG04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/24]CZ04.08.2021
EE04.08.2021
HR04.08.2021
LT04.08.2021
LV04.08.2021
RS04.08.2021
SK04.08.2021
BG04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/10]HR04.08.2021
LT04.08.2021
LV04.08.2021
RS04.08.2021
BG04.11.2021
GR05.11.2021
IS04.12.2021
PT06.12.2021
Former [2022/09]LT04.08.2021
RS04.08.2021
BG04.11.2021
PT06.12.2021
Former [2022/08]LT04.08.2021
BG04.11.2021
Documents cited:Search[XP]WO2014160579  (INSITE VISION INC [US]) [XP] 1-15 * abstract * * page 58 * * example I * * claims 1-15 *;
 [X]WO2013063695  (KANE BIOTECH INC [CA], et al) [X] 1-15 * abstract * * paragraph [0015] - paragraph [0031] * * paragraph [0054] - paragraph [0067] * * examples 1-17 * * claims 1-42 *
International search[PX]WO2014134701  (KANE BIOTECH INC [CA]) [PX] 1-36 * entire document *;
 [X]WO03047341  (ASEPTICA INC [US], et al) [X] 1, 2, 15, 16, 21-36 * entire document *;
 [XY]WO2005097067  (BAUSCH & LOMB [US], et al) [X] 1-4, 12-16, 18, 21-36 * entire document * [Y] 1-36;
 [A]WO2014100777  (BHUSHAN RAJIV [US], et al) [A] 1-36 * entire document *
 [XY]  - R.M.Q. SHANKS et al., "Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces", Nephrol. Dial Transplant, (20060420), vol. 21, no. 8, ISSN 0931-0509, pages 2247 - 2255, XP055019128 [X] 1, 2, 12-17, 21-29 * entire document * [Y] 1-36

DOI:   http://dx.doi.org/10.1093/ndt/gfl170
Examination   - Anon, "Ethylenediaminetetracetic acid", Wikipedia, (20030212), URL: https://en.wikipedia.org/wiki/Ethylenediaminetetraacetic_acid, (20190807), XP055611599
    - RODNEY M. DONLAN, "Biofilm Formation: A Clinically Relevant Microbiological Process", CLINICAL INFECTIOUS DISEASES, US, (20011015), vol. 33, no. 8, doi:10.1086/322972, ISSN 1058-4838, pages 1387 - 1392, XP055769885

DOI:   http://dx.doi.org/10.1086/322972
by applicantWO2013063695
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.